Position in FTRE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$21,643,084
-$20,923,443 QoQ
Shares Held
2,297,568
-6.9% QoQ
Ownership
2.43%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 95.01777531720498.ToString("F0")%
Shared 0.ToString("F0")%
None 4.982224682795025.ToString("F0")%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,438,935,225 across 518 Biotechnology names. FTRE ranks #89 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in FTRE
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,643,084 | 2,297,568 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $42,566,527 | 2,467,625 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $23,639,446 | 2,807,536 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $13,132,316 | 2,658,365 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $40,882,913 | 5,414,956 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $19,479,154 | 1,044,459 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $25,557,420 | 1,277,871 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $43,163,307 | 1,849,328 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $61,015,041 | 1,520,056 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $65,412,713 | 1,874,290 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $50,885,531 | 1,779,837 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $986 | 29 | Shares | Defined | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||